Micah Pearlman, Chief Operating Officer and Co-Founder

Professional Overview

Micah Pearlman is an accomplished pharmaceutical executive with over a decade of experience in strategic planning, operational transformation, and research and development. As the Chief Operating Officer and Co-Founder of Aulos Bioscience, he leads the company's day-to-day operations, driving the development of innovative biopharmaceutical solutions. Micah also serves as the Chief Operating Officer at Biolojic Design, Ltd., leveraging his expertise in the biotech industry to guide the company's growth and operational excellence.

Experience Summary

Current Roles

Chief Operating Officer and Co-Founder, Aulos Bioscience (2020-present)

Responsible for the overall operations and strategic direction of the company, overseeing cross-functional teams to accelerate the development of novel therapeutics

Spearheaded the implementation of efficient processes and systems, resulting in significant improvements in productivity and time-to-market

Played a pivotal role in securing funding and strategic partnerships to support Aulos Bioscience's ambitious growth plans

Chief Operating Officer, Biolojic Design, Ltd. (2018-present)

Provides strategic leadership and operational oversight for the company, ensuring the effective execution of research and development initiatives

Drives the implementation of best practices and industry standards to enhance the company's operational efficiency and product quality

Collaborates closely with the executive team to identify and capitalize on emerging market opportunities

Career Progression

Director of Strategy and Transformation, Global R&D at Teva Pharmaceuticals (2016-2018)

Developed and implemented comprehensive transformation strategies to optimize the company's global R&D operations, leading to enhanced productivity and cost savings

Spearheaded the integration of new technologies and digital solutions to streamline processes and improve decision-making

Played a key role in the successful launch of several new products, contributing to the company's revenue growth

Manager, R&D and Higher Education Sector (Budget Department) at Israel Ministry of Finance (2012-2015)

Oversaw the allocation of government funding and resources to support research and development initiatives in the pharmaceutical and biotechnology sectors

Collaborated with industry stakeholders to identify and address regulatory and policy barriers, facilitating the growth of the Israeli life sciences ecosystem

Played a pivotal role in the development and implementation of policies that strengthened the country's higher education system

Head, Public Transportation Branch (Budget Department) at Israel Ministry of Finance (2009-2011)

Managed the budget allocation and strategic planning for the country's public transportation infrastructure, ensuring the efficient utilization of resources

Worked closely with government agencies and transportation providers to identify and address operational challenges, improving the accessibility and reliability of public transit

Academic Background

Micah Pearlman holds a Bachelor's degree in Economics and Business Administration from the Hebrew University of Jerusalem, where he graduated with distinction.

Areas of Expertise

Strategic planning and operational optimization

Research and development management

Pharmaceutical industry regulatory compliance

Innovative technology integration and digital transformation

Stakeholder engagement and partnership development

Budgeting and resource allocation

Professional Impact

Instrumental in driving the growth and operational excellence of multiple biotech and pharmaceutical companies, leading to the successful development and commercialization of new products

Recognized as a thought leader in the Israeli life sciences ecosystem, contributing to the development of industry-shaping policies and regulations

Demonstrated a proven track record of delivering measurable improvements in productivity, efficiency, and financial performance across diverse organizations

Conclusion

Micah Pearlman's extensive experience in the pharmaceutical and biotechnology industries, coupled with his proven leadership and strategic acumen, positions him as a valuable asset in driving the growth and operational success of organizations in the life sciences sector. His deep understanding of industry trends, regulatory frameworks, and technological innovations, combined with his collaborative approach, make him a trusted partner in navigating the complex challenges and seizing the opportunities that define the ever-evolving landscape of the biopharmaceutical industry.